GoKawiil
Tech News
New research reports that colorectal cancer diagnosed in people aged 20 and under tends to be more aggressive and is often caught later than in adults. The findings indicate these pediatric and adolescent cases may represent a biologically distinct form of the disease rather than simply an early-onset version of adult colorectal cancer.
Researchers report that a young boy's cancer went into remission after receiving an experimental form of CAR T cell therapy. The treatment is part of ongoing efforts to adapt CAR T technology, previously effective mainly against blood cancers, to target solid tumors.
A young boy with hepatoblastoma that had spread to his lungs and stopped responding to chemotherapy achieved complete remission after receiving an experimental CAR-T cell treatment. The therapy, part of the CARE study, engineered the patient's own immune cells to target glypican-3, a protein found on liver cancer cells, while also boosting the cells' potency with two added immune signaling proteins. Twelve months after treatment, doctors report no detectable trace of the cancer.